Literature DB >> 18360744

Oligonucleotide microarray analysis of genes regulating apoptosis in chronically ischemic and postinfarction myocardium.

Józefa Dabek1, Aleksander Owczarek, Zbigniew Gasior, Rafal Ulczok, Mariusz Skowerski, Andrzej Kułach, Urszula Mazurek, Andrzej Bochenek.   

Abstract

The pathology of cardiomyocyte death during and after myocardial infarction involves both necrosis and apoptosis. Although both mechanisms lead to cell death, participation of apoptosis in this process carries the potential of developing therapies influencing at least part of the population of dying cells. Therefore the aim of this study was to determine (using oligonucleotide microarrays) expression profiles of apoptosis-regulating genes in postinfarction myocardium, comparing chronically ischemic and healthy heart muscle. Tissue samples were obtained during elective surgery from the right cardiac auricles of three patients. The expression of 141 genes involved in fibrosis was assessed using the Affymetrix HG_U133A microarray. The patients' transcriptomes were compared using hierarchical clusterization. Differentiating genes were determined using regression analysis and Bland-Altman graph analysis. Hierarchical clusterization demonstrated that the profile of gene expression in postinfarction myocardium was different from that in the remaining specimens. Further statistical analysis showed two important differentiating genes: FOXO3A (underexpressed in post-MI sample) and CFLAR (overexpressed in post-MI sample). The expression of apoptosis-regulating genes is significantly different in post-MI myocardium from chronically ischemic and a nonischemic myocardium. Our results suggest that CFLAR is important in the induction of apoptosis in postinfarction cardiac tissue.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18360744     DOI: 10.1007/s10528-007-9137-3

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  6 in total

1.  Genetic association of FOXO1A and FOXO3A with longevity trait in Han Chinese populations.

Authors:  Yang Li; Wen-Jing Wang; Huiqing Cao; Jiehua Lu; Chong Wu; Fang-Yuan Hu; Jian Guo; Ling Zhao; Fan Yang; Yi-Xin Zhang; Wei Li; Gu-Yan Zheng; Hanbin Cui; Xiaomin Chen; Zhiming Zhu; Hongbo He; Birong Dong; Xianming Mo; Yi Zeng; Xiao-Li Tian
Journal:  Hum Mol Genet       Date:  2009-09-29       Impact factor: 6.150

2.  Association study to evaluate FoxO1 and FoxO3 gene in CHD in Han Chinese.

Authors:  Ying Zhao; Yanbo Yu; Xiaoli Tian; Xi Yang; Xueqi Li; Feng Jiang; Yundai Chen; Maowei Shi
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

Review 3.  Forkhead box transcription factor 1: role in the pathogenesis of diabetic cardiomyopathy.

Authors:  Vidya Kandula; Ramoji Kosuru; Haobo Li; Dan Yan; Qiqi Zhu; Qingquan Lian; Ren-Shan Ge; Zhengyuan Xia; Michael G Irwin
Journal:  Cardiovasc Diabetol       Date:  2016-03-08       Impact factor: 9.951

4.  Long non-coding RNA-ROR aggravates myocardial ischemia/reperfusion injury.

Authors:  Weiwei Zhang; Ying Li; Peng Wang
Journal:  Braz J Med Biol Res       Date:  2018-04-23       Impact factor: 2.590

5.  Expression profiles of long noncoding RNAs and messenger RNAs in the border zone of myocardial infarction in rats.

Authors:  Qingkun Meng; Zhijun Sun; Hui Gu; Jiaying Luo; Jingjing Wang; Chuanhe Wang; Su Han
Journal:  Cell Mol Biol Lett       Date:  2019-12-02       Impact factor: 5.787

6.  The Association Between Longevity-Associated FOXO3 Allele and Heart Disease in Septuagenarians and Octogenarians: The SONIC Study.

Authors:  Nonglak Klinpudtan; Richard C Allsopp; Mai Kabayama; Kayo Godai; Yasuyuki Gondo; Yukie Masui; Yuya Akagi; Werayuth Srithumsuk; Ken Sugimoto; Hiroshi Akasaka; Yoichi Takami; Yasushi Takeya; Koichi Yamamoto; Kazunori Ikebe; Saori Yasumoto; Madoka Ogawa; Tatsuro Ishizaki; Yasumichi Arai; Hiromi Rakugi; Randi Chen; Bradley J Willcox; D Craig Willcox; Kei Kamide
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-08-12       Impact factor: 6.591

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.